Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curpap: Prophylactic Curosurf + nCPAP vs nCPAP alone in preterm infants
NCT00501982Phase 4Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Mar 2007
- Primary completion
- May 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 5
01
Overview
A Phase 4 trial of Poractant alfa in respiratory distress syndrome (RDS), sponsored by Chiesi Farmaceutici S.p.A.. Started Mar 2007; status: completed.
02
Drugs
Poractant alfa
03
Conditions
respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on NCT00501982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00501982.